Oncolytic adenoviruses as a therapeutic approach for osteosarcoma: A new hope
Osteosarcoma is the most common bone cancer among those with non-hematological origin and affects mainly pediatric patients. In the last 50 years, refinements in surgical procedures, as well as the introduction of aggressive neoadjuvant and adjuvant chemotherapeutic cocktails, have increased to near...
Main Authors: | Marc Garcia-Moure, Naiara Martinez-Vélez, Ana Patiño-García, Marta M. Alonso |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-11-01
|
Series: | Journal of Bone Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212137416300732 |
Similar Items
-
Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01.
by: Beatriz Vera, et al.
Published: (2016-01-01) -
Correction: Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01.
by: Beatriz Vera, et al.
Published: (2016-01-01) -
Oncolytic Viruses as Therapeutic Tools for Pediatric Brain Tumors
by: Maider Varela-Guruceaga, et al.
Published: (2018-07-01) -
Oncolytic Adenovirus in Cancer Immunotherapy
by: Malin Peter, et al.
Published: (2020-11-01) -
Oncolytic Adenoviruses in Cancer Treatment
by: Ramon Alemany
Published: (2014-02-01)